Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
207.29
171.93
167.56
164.40
135.09
135.21
123.72
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
207.29
171.93
167.56
164.40
135.09
135.21
123.72
Raw Material Cost
138.13
114.98
130.26
108.98
81.28
85.39
80.23
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.16
0.15
0.19
0.45
0.02
0.03
0.06
Selling and Distribution Expenses
16.65
15.33
9.16
14.36
10.18
11.06
8.55
Other Expenses
1.05
0.86
0.81
0.89
0.78
0.82
0.85
Total Expenditure (Excl Depreciation)
165.46
139.03
147.72
132.68
99.24
104.69
97.31
Operating Profit (PBDIT) excl Other Income
41.8
32.9
19.8
31.7
35.8
30.5
26.400000000000002
Other Income
-0.13
2.62
-8.33
7.71
8.26
10.36
23.55
Operating Profit (PBDIT)
50.86
44.32
28.36
36.94
49.63
46.07
52.82
Interest
0.16
0.15
0.19
0.45
0.02
0.03
0.06
Exceptional Items
4.19
4.53
-0.57
2.37
4.13
1.32
-2.90
Gross Profit (PBDT)
69.16
56.95
37.31
55.42
53.80
49.82
43.49
Depreciation
11.07
11.07
12.15
12.15
6.99
6.99
5.78
Profit Before Tax
43.82
37.63
15.44
26.71
46.75
40.37
44.09
Tax
7.15
4.92
3.84
3.35
5.66
5.57
6.37
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
37.30
33.44
15.41
23.35
41.09
34.80
37.72
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
37.30
33.44
15.41
23.35
41.09
34.80
37.72
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.62
-0.73
-3.81
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
36.68
32.71
11.61
23.35
41.09
34.80
37.72
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,400.51
2,388.89
2,352.85
2,349.43
2,318.85
2,305.48
2,268.27
Earnings per share (EPS)
0.35
0.31
0.14
0.22
0.38
0.32
0.35
Diluted Earnings per share
0.35
0.31
0.14
0.22
0.38
0.32
0.35
Operating Profit Margin (Excl OI)
19.26%
17.81%
14.65%
10.39%
25.45%
21.24%
18.99%
Gross Profit Margin
26.48%
28.32%
16.46%
23.63%
39.78%
35.02%
40.31%
PAT Margin
17.99%
19.45%
9.2%
14.21%
30.41%
25.74%
30.49%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 53.44% vs 0.97% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is -10.71% vs 14.17% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 23.19% vs 28.57% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 0.00% vs 0.00% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Compare Quarterly Results Of Suzhou Highfine Biotech Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
207.29
0
207.29
Other Operating Income
0.00
0.00
0.00
Total Operating income
207.29
0
207.29
Raw Material Cost
138.13
0
138.13
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.16
0
0.16
Selling and Distribution Expenses
16.65
0
16.65
Other Expenses
1.05
0.00
1.05
Total Expenditure (Excl Depreciation)
165.46
0
165.46
Operating Profit (PBDIT) excl Other Income
41.83
0.00
41.83
Other Income
-0.13
0
-0.13
Operating Profit (PBDIT)
50.86
0
50.86
Interest
0.16
0
0.16
Exceptional Items
4.19
0
4.19
Gross Profit (PBDT)
69.16
0
69.16
Depreciation
11.07
0
11.07
Profit Before Tax
43.82
0
43.82
Tax
7.15
0
7.15
Provisions and contingencies
0
0
0.00
Profit After Tax
37.30
0
37.30
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
37.30
0
37.30
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.62
0
-0.62
Other related items
0.00
0.00
0.00
Consolidated Net Profit
36.68
0
36.68
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,400.51
0
2,400.51
Earnings per share (EPS)
0.35
0
0.35
Diluted Earnings per share
0.35
0
0.35
Operating Profit Margin (Excl OI)
19.26%
0%
0.00
19.26%
Gross Profit Margin
26.48%
0%
0.00
26.48%
PAT Margin
17.99%
0%
0.00
17.99%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 20.73 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 20.59% vs 2.57% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 53.44% vs 0.97% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 3.67 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 12.23% vs 181.90% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -10.71% vs 14.17% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.10 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 22.30% vs 13.62% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 23.19% vs 28.57% in Jun 2025
Quarterly - Interest
Interest 0.02 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 0.00% vs 0.00% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 0.00% vs 0.00% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.26%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Footer loading
